PL375883A1 - Water-soluble polymer alkanals - Google Patents

Water-soluble polymer alkanals

Info

Publication number
PL375883A1
PL375883A1 PL03375883A PL37588303A PL375883A1 PL 375883 A1 PL375883 A1 PL 375883A1 PL 03375883 A PL03375883 A PL 03375883A PL 37588303 A PL37588303 A PL 37588303A PL 375883 A1 PL375883 A1 PL 375883A1
Authority
PL
Poland
Prior art keywords
water
soluble polymer
polymer alkanals
alkanals
soluble
Prior art date
Application number
PL03375883A
Other languages
Polish (pl)
Inventor
Antoni Kozlowski
Original Assignee
Nektar Therapeutics Al, Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nektar Therapeutics Al, Corporation filed Critical Nektar Therapeutics Al, Corporation
Publication of PL375883A1 publication Critical patent/PL375883A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A61K47/60—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes the organic macromolecular compound being a polyoxyalkylene oligomer, polymer or dendrimer, e.g. PEG, PPG, PEO or polyglycerol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C43/00—Ethers; Compounds having groups, groups or groups
    • C07C43/30—Compounds having groups
    • C07C43/315—Compounds having groups containing oxygen atoms singly bound to carbon atoms not being acetal carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/27—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation
    • C07C45/30—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by oxidation with halogen containing compounds, e.g. hypohalogenation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C47/00—Compounds having —CHO groups
    • C07C47/02—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen
    • C07C47/198—Saturated compounds having —CHO groups bound to acyclic carbon atoms or to hydrogen containing ether groups, groups, groups, or groups
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/26—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds
    • C08G65/2603—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring from cyclic ethers and other compounds the other compounds containing oxygen
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/02—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from cyclic ethers by opening of the heterocyclic ring
    • C08G65/32—Polymers modified by chemical after-treatment
    • C08G65/329—Polymers modified by chemical after-treatment with organic compounds
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G65/00—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule
    • C08G65/34—Macromolecular compounds obtained by reactions forming an ether link in the main chain of the macromolecule from hydroxy compounds or their metallic derivatives
    • C08G65/48—Polymers modified by chemical after-treatment
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L2203/00—Applications
    • C08L2203/02—Applications for biomedical use

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Polyethers (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
  • Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
PL03375883A 2002-09-09 2003-09-09 Water-soluble polymer alkanals PL375883A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US40925102P 2002-09-09 2002-09-09
US45658003P 2003-03-19 2003-03-19
PCT/US2003/028221 WO2004022630A2 (en) 2002-09-09 2003-09-09 Water-soluble polymer alkanals

Publications (1)

Publication Number Publication Date
PL375883A1 true PL375883A1 (en) 2005-12-12

Family

ID=31981629

Family Applications (1)

Application Number Title Priority Date Filing Date
PL03375883A PL375883A1 (en) 2002-09-09 2003-09-09 Water-soluble polymer alkanals

Country Status (22)

Country Link
US (5) US7157546B2 (en)
EP (1) EP1546235B1 (en)
JP (2) JP4764630B2 (en)
KR (2) KR20050093856A (en)
AP (2) AP2005003249A0 (en)
AU (1) AU2003270454B2 (en)
BR (1) BR0314172A (en)
CA (1) CA2498167C (en)
EA (1) EA200500475A1 (en)
EC (1) ECSP055654A (en)
ES (1) ES2897470T3 (en)
GE (1) GEP20074193B (en)
HR (2) HRP20050320A2 (en)
IS (1) IS7789A (en)
MA (1) MA27401A1 (en)
MX (1) MXPA05002620A (en)
NO (2) NO20051078L (en)
NZ (2) NZ538624A (en)
PL (1) PL375883A1 (en)
RS (2) RS20050202A (en)
UA (1) UA80838C2 (en)
WO (1) WO2004022630A2 (en)

Families Citing this family (53)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7053150B2 (en) 2000-12-18 2006-05-30 Nektar Therapeutics Al, Corporation Segmented polymers and their conjugates
PT3025726T (en) 2002-01-18 2020-01-09 Biogen Ma Inc POLYALKYLENE POLYMER COMPOUNDS AND USES OF THE SAME
DE10209821A1 (en) 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of proteins to a modified polysaccharide
DE10209822A1 (en) * 2002-03-06 2003-09-25 Biotechnologie Ges Mittelhesse Coupling of low molecular weight substances to a modified polysaccharide
KR20050093856A (en) 2002-09-09 2005-09-23 넥타르 테라퓨틱스 에이엘, 코포레이션 Water-soluble polymer alkanals
BR0314227A (en) 2002-09-11 2005-10-25 Fresenius Kabi De Gmbh Hydroxyalkyl Starch Derivatives
JP5207590B2 (en) * 2002-12-26 2013-06-12 マウンテン ビュー ファーマシューティカルズ，インコーポレイテッド Polymer conjugate of interferon-beta with enhanced biological ability
GEP20084487B (en) * 2002-12-26 2008-09-25 Mountain View Pharmaceuticals Polymer conjugates of cytokines, chemokines, growth factors, polypeptide hormones and antagonists thereof
BRPI0407882B1 (en) * 2003-02-26 2021-07-27 Nektar Therapeutics COMPOSITION INCLUDING POLYMER CONJUGATES - PORTION OF FACTOR VIII AND THEIR MANUFACTURING METHOD
US7947261B2 (en) 2003-05-23 2011-05-24 Nektar Therapeutics Conjugates formed from polymer derivatives having particular atom arrangements
GB0314472D0 (en) 2003-06-20 2003-07-23 Warwick Effect Polymers Ltd Polymer
PL1660134T3 (en) * 2003-08-08 2011-05-31 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and g-csf
WO2005014655A2 (en) 2003-08-08 2005-02-17 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkyl starch and a protein
ES2390885T3 (en) * 2004-03-11 2012-11-19 Fresenius Kabi Deutschland Gmbh Conjugates of hydroxyalkylamidone and a protein
JP5191729B2 (en) 2004-03-11 2013-05-08 フレゼニウス・カビ・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング Conjugates of hydroxyalkyl starch and protein produced by reductive amination
KR101276422B1 (en) 2004-03-15 2013-06-19 넥타르 테라퓨틱스 Polymer-based compositions and conjugates of hiv entry inhibitors
AU2005229001A1 (en) * 2004-03-23 2005-10-13 Amgen Inc. Chemically modified protein compositions and methods
CN101031323A (en) * 2004-07-16 2007-09-05 尼克塔治疗亚拉巴马公司 Conjugates of gm-csf moiety and a polymer
KR20070042567A (en) * 2004-08-31 2007-04-23 파마시아 앤드 업존 캄파니 엘엘씨 Glycerol Branched Polyethylene Glycol Human Growth Hormone Conjugates, Methods for Making the Same and Methods for Using the Same
US7612153B2 (en) * 2004-10-25 2009-11-03 Intezyne Technologies, Inc. Heterobifunctional poly(ethylene glycol) and uses thereof
CN101137396A (en) * 2005-03-11 2008-03-05 弗雷泽纽斯卡比德国有限公司 Preparation of bioactive glycoproteins from inactive starting materials
WO2007010552A2 (en) * 2005-03-17 2007-01-25 Serum Institute Of India Limited N- terminal peg conjugate of erythropoietin
US20060233740A1 (en) * 2005-03-23 2006-10-19 Bossard Mary J Conjugates of an hGH moiety and a polymer
EP1762250A1 (en) * 2005-09-12 2007-03-14 Fresenius Kabi Deutschland GmbH Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
EP2364735A3 (en) 2005-12-16 2012-04-11 Nektar Therapeutics Branched PEG conjugates of GLP-1
EP1834963A1 (en) * 2006-03-13 2007-09-19 Siegfried Ltd. Di-polymer protein conjugates and processes for their preparation
CA2650035C (en) 2006-04-27 2015-02-03 Intezyne Technologies, Inc. Poly (ethylene glycol) containing chemically disparate endgroups
CL2008002399A1 (en) * 2007-08-16 2009-01-02 Pharmaessentia Corp Substantially pure conjugate having a polymeric portion, a protein portion (interferon alpha 2b) and an aliphatic binder of 1 to 10 carbon atoms, useful in the treatment of hepatitis b or c.
EP2070951A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Method for producing a hydroxyalkyl starch derivatives with two linkers
EP2070950A1 (en) 2007-12-14 2009-06-17 Fresenius Kabi Deutschland GmbH Hydroxyalkyl starch derivatives and process for their preparation
EP2254601B1 (en) 2008-02-08 2019-05-29 Nektar Therapeutics Oligomer-cannabinoid conjugates
KR100967833B1 (en) * 2008-05-20 2010-07-05 아이디비켐(주) Method for producing high purity polyethylene glycol aldehyde derivative
AR072850A1 (en) * 2008-07-31 2010-09-22 Pharmaessentia Corp PEPTIDO-POLYMER CONJUGATES
JP5766118B2 (en) 2008-09-11 2015-08-19 ウェルズ ファーゴ バンク ナショナル アソシエイション Polymeric alpha-hydroxyaldehyde and ketone reagents and conjugation methods
EP2344200A2 (en) * 2008-09-19 2011-07-20 Nektar Therapeutics Modified therapeutics peptides, methods of their preparation and use
WO2010033240A2 (en) 2008-09-19 2010-03-25 Nektar Therapeutics Carbohydrate-based drug delivery polymers and conjugates thereof
GB0823309D0 (en) * 2008-12-19 2009-01-28 Univ Bath Functionalising reagents and their uses
JP5602850B2 (en) 2009-07-14 2014-10-08 ザ スクリプス リサーチ インスティテュート Mesenchymal stem cell differentiation
KR20130115086A (en) 2010-05-17 2013-10-21 세빅스 인코포레이티드 Pegylated c-peptide
RU2447083C1 (en) * 2010-07-20 2012-04-10 Закрытое Акционерное Общество "Биокад" NOVEL FUNCTIONALLY ACTIVE, HIGHLY PURE, STABLE CONJUGATE OF INTERFERON α WITH POLYETHYLENE GLYCOL, REPRESENTED BY ONE PEG- NαH-IFN POSITIONAL ISOMER, WITH IMPROVED IMMUNOGENICITY, WITH PROLONGED BIOLOGICAL ACTION, SUITABLE FOR MEDICAL APPLICATION, AND IMMUNOLOGICAL AGENT BASED THEREON
WO2012054822A1 (en) 2010-10-22 2012-04-26 Nektar Therapeutics Pharmacologically active polymer-glp-1 conjugates
WO2012065086A1 (en) 2010-11-12 2012-05-18 Nektar Therapeutics Conjugates of an il-2 moiety and a polymer
EP2540325B1 (en) * 2011-06-27 2016-08-10 Greatbatch Ltd. Peptide based antimicrobial coating
EP2592103A1 (en) * 2011-11-08 2013-05-15 Adriacell S.p.A. Polymer aldehyde derivatives
JP5999659B2 (en) * 2011-12-14 2016-09-28 国立大学法人 筑波大学 Novel branched polyethylene glycol and its use
UY35368A (en) 2013-03-08 2014-10-31 Irm Llc PEPTIDES AND COMPOSITIONS FOR THE TREATMENT OF ARTICULAR DAMAGE
MA38369B1 (en) 2013-03-08 2018-10-31 Novartis Ag Peptides and compositions for the treatment of a lesion of the joint
JP6106103B2 (en) * 2014-01-16 2017-03-29 信越化学工業株式会社 Method for producing narrowly dispersed polyalkylene glycol derivative having amino group at terminal, and novel acetal group-containing alcohol compound and alkali metal salt thereof used therefor
JP6106104B2 (en) 2014-01-16 2017-03-29 信越化学工業株式会社 Method for producing narrowly dispersed polyalkylene glycol derivative having amino group at terminal
GB201419108D0 (en) 2014-10-27 2014-12-10 Glythera Ltd Materials and methods relating to linkers for use in antibody drug conjugates
JP6820841B2 (en) 2014-11-06 2021-01-27 ファーマエッセンティア コーポレイション Dosing regimen for pegged interferon
WO2017062832A1 (en) 2015-10-08 2017-04-13 Nektar Therapeutics Combination of an il-2rbeta-selective agonist and a long-acting il-15 agonist
TW202027794A (en) 2018-10-03 2020-08-01 瑞士商諾華公司 Sustained delivery of angiopoetin-like 3 polypeptides

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4002531A (en) * 1976-01-22 1977-01-11 Pierce Chemical Company Modifying enzymes with polyethylene glycol and product produced thereby
JPS5695142A (en) * 1979-12-28 1981-08-01 T Hasegawa Co Ltd Preparation of aliphatic aldehyde
JPS63152393A (en) * 1986-07-03 1988-06-24 Takeda Chem Ind Ltd Glycosyl derivative
US5037969A (en) * 1986-07-03 1991-08-06 Takeda Chemical Industries, Ltd. Glycosyl derivatives and use thereof
US5510418A (en) * 1988-11-21 1996-04-23 Collagen Corporation Glycosaminoglycan-synthetic polymer conjugates
WO1990005534A1 (en) 1988-11-23 1990-05-31 Genentech, Inc. Polypeptide derivatives
US5252714A (en) * 1990-11-28 1993-10-12 The University Of Alabama In Huntsville Preparation and use of polyethylene glycol propionaldehyde
JPH06233816A (en) 1993-02-12 1994-08-23 Toyobo Co Ltd Hemocatharsis adsorbent
US5840900A (en) * 1993-10-20 1998-11-24 Enzon, Inc. High molecular weight polymer-based prodrugs
US5919455A (en) 1993-10-27 1999-07-06 Enzon, Inc. Non-antigenic branched polymer conjugates
US5627662A (en) 1994-04-28 1997-05-06 Xerox Corporation Digital imaging system using two-dimensional input sensor array and output light valve
FR2724459B1 (en) 1994-09-14 1997-05-09 Univ Compiegne Tech AFFINITY CAPILLARY ELECTROPHORESIS, AFFINITY MATRIX FOR THE IMPLEMENTATION OF THIS ELECTROPHORESIS AND ITS MANUFACTURING METHOD
US5824784A (en) * 1994-10-12 1998-10-20 Amgen Inc. N-terminally chemically modified protein compositions and methods
US5672662A (en) * 1995-07-07 1997-09-30 Shearwater Polymers, Inc. Poly(ethylene glycol) and related polymers monosubstituted with propionic or butanoic acids and functional derivatives thereof for biotechnical applications
US5736543A (en) * 1996-04-03 1998-04-07 The Regents Of The University Of California Benzoxazines for enhancing synaptic response
US5990237A (en) * 1997-05-21 1999-11-23 Shearwater Polymers, Inc. Poly(ethylene glycol) aldehyde hydrates and related polymers and applications in modifying amines
JPH11322916A (en) 1998-05-11 1999-11-26 Kazunori Kataoka Heterotelechelic polymer having biotin residue at one end
US6420555B1 (en) * 1998-06-16 2002-07-16 Societe De Conseils De Recherches Et D'applications Scientifiques, S.A.S. Imidazolyl derivatives
AU1325400A (en) * 1998-10-26 2000-05-15 University Of Utah Research Foundation Method for preparation of polyethylene glycol aldehyde derivatives
EP1135493A2 (en) 1998-11-30 2001-09-26 Eli Lilly And Company Erythropoietic compounds
JP2000303090A (en) * 1999-04-20 2000-10-31 T Hasegawa Co Ltd Perfume composition
CA2394980C (en) * 1999-12-22 2008-05-13 Shearwater Corporation Sterically hindered derivatives of water soluble polymers
TW593427B (en) 2000-12-18 2004-06-21 Nektar Therapeutics Al Corp Synthesis of high molecular weight non-peptidic polymer derivatives
EP1446438A2 (en) 2001-11-07 2004-08-18 Nektar Therapeutics Al, Corporation Branched polymers and their conjugates
WO2003044056A2 (en) 2001-11-20 2003-05-30 Pharmacia Corporation Chemically-modified human growth hormone conjugates
US20030171285A1 (en) * 2001-11-20 2003-09-11 Finn Rory F. Chemically-modified human growth hormone conjugates
US6956135B2 (en) * 2001-12-11 2005-10-18 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
AU2002357806A1 (en) 2001-12-11 2003-06-23 Sun Bio, Inc. Novel monofunctional polyethylene glycol aldehydes
US6916962B2 (en) * 2001-12-11 2005-07-12 Sun Bio, Inc. Monofunctional polyethylene glycol aldehydes
PT3025726T (en) 2002-01-18 2020-01-09 Biogen Ma Inc POLYALKYLENE POLYMER COMPOUNDS AND USES OF THE SAME
EP1503367A4 (en) * 2002-04-26 2007-05-30 Prime Polymer Co Ltd DEVICE AND STRUCTURAL ELEMENT FOR ABSORPTION OF NOISE AND ASSOCIATED MANUFACTURING METHOD
ATE344289T1 (en) * 2002-07-24 2006-11-15 Hoffmann La Roche POLYETHYLENE GLYCOL ALDEHYDE DERIVATIVES
KR20050093856A (en) * 2002-09-09 2005-09-23 넥타르 테라퓨틱스 에이엘, 코포레이션 Water-soluble polymer alkanals
US20040142870A1 (en) * 2002-11-20 2004-07-22 Finn Rory F. N-terminally monopegylated human growth hormone conjugates, process for their preparation, and methods of use thereof
TWI281864B (en) * 2002-11-20 2007-06-01 Pharmacia Corp N-terminally monopegylated human growth hormone conjugates and process for their preparation
US6961962B1 (en) 2004-09-09 2005-11-08 Morning Pride Manufacturing, L.L.C. Combined closure and liner zippers employing common zipper tapes and protective garment employing said combined zippers
JP5084245B2 (en) 2006-06-07 2012-11-28 関西ペイント株式会社 Starch-based paint composition

Also Published As

Publication number Publication date
EA200500475A1 (en) 2005-10-27
MXPA05002620A (en) 2005-05-05
JP2005538224A (en) 2005-12-15
UA80838C2 (en) 2007-11-12
US7838595B2 (en) 2010-11-23
GEP20074193B (en) 2007-09-10
BR0314172A (en) 2005-07-26
US7157546B2 (en) 2007-01-02
EP1546235B1 (en) 2021-10-20
MA27401A1 (en) 2005-06-01
CA2498167C (en) 2012-03-20
AP2005003246A0 (en) 2005-03-31
NO20051078L (en) 2005-04-08
US20120065429A1 (en) 2012-03-15
US8076412B2 (en) 2011-12-13
AU2003270454A1 (en) 2004-03-29
KR20050093856A (en) 2005-09-23
HRP20050319A2 (en) 2006-12-31
US8853325B2 (en) 2014-10-07
NO20051077L (en) 2005-04-08
IS7789A (en) 2005-04-08
AU2003270454B2 (en) 2010-05-20
KR20050057281A (en) 2005-06-16
HRP20050320A2 (en) 2006-12-31
US7511094B2 (en) 2009-03-31
ECSP055654A (en) 2005-05-30
EP1546235A2 (en) 2005-06-29
JP4764630B2 (en) 2011-09-07
US20040116649A1 (en) 2004-06-17
WO2004022630A3 (en) 2004-04-15
RS20050203A (en) 2007-08-03
US20110034737A1 (en) 2011-02-10
NZ538624A (en) 2007-01-26
JP2005350470A (en) 2005-12-22
ES2897470T3 (en) 2022-03-01
US20090234070A1 (en) 2009-09-17
NZ540490A (en) 2007-10-26
CA2498167A1 (en) 2004-03-18
US20060194940A1 (en) 2006-08-31
KR100974843B1 (en) 2010-08-11
WO2004022630A2 (en) 2004-03-18
AP2005003249A0 (en) 2005-03-31
RS20050202A (en) 2007-08-03

Similar Documents

Publication Publication Date Title
AP2005003246A0 (en) Water-soluble polymer alkanals
GB0222522D0 (en) Water-swellable polymers
AU2003211925A1 (en) Block copolymer
AU2003293082A1 (en) Antioxidant-functionalized polymers
PL372728A1 (en) Polyalkylene polymer compounds and uses thereof
PL1660597T3 (en) Copolymer surfactants
AU2003902496A0 (en) Garment
GB0321383D0 (en) Polymer circuits
AU2003241279A8 (en) Antimicrobial polymer conjugates
DE60333033D1 (en) Pulverförmiges thermoplastisches polymer
AU2002225394A1 (en) Block copolymer
AU2003267540A8 (en) Biodegradable polymer
GB2393446B (en) Polymer
GB0307643D0 (en) Markers
AU2003272053A8 (en) Polymer microneedles
GB2398790B (en) Polymer compositions
ZA200502507B (en) Water-soluble polymer alkanals.
AU2003244788A1 (en) Polymeric based complex
HK1074054A (en) Water-soluble polymer alkanals
GB0200505D0 (en) Highly functional polymers
GB0307640D0 (en) Markers
GB0201593D0 (en) Ferromagnetic polymer
GB0326138D0 (en) Polymers, their preparation and uses
GB0104284D0 (en) Polymer
GB0113194D0 (en) Polymer

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)
DISD Decisions on discontinuance of the proceedings of a derived patent or utility model

Ref document number: 375884

Country of ref document: PL